News
Nexus Dx Appoints Joseph M. Nemmers, Jr. to Its Board of Directors
March 3, 2011
Nexus Dx Inc., founded in 2009 to consolidate technologies focused on point-of-care (POC) blood diagnostic testing, is pleased to announce the appointment of Joseph M. Nemmers, Jr. to the Company’s Board of Directors, effective immediately. Mr. Nemmers is the Principal in a private consulting practice specializing in the pharmaceutical and medical device industries, and serves as an advisor to Warburg Pincus LLC. Read more…
Nexus Dx Names Gordon Sangster as Chief Financial Officer
February 22, 2011
Nexus Dx Inc., founded in 2009 to consolidate technologies focused on point-of-care (POC) blood diagnostic testing, has named Gordon Sangster as the Company’s new V.P. of Finance and Chief Financial Officer (CFO), effective immediately. As a key member of the Nexus Dx executive leadership team, Sangster will be actively involved in overall financial management, corporate strategic planning, business process improvement and corporate administration. He will report to Nexus Dx President and Chief Executive Officer, Jim Merselis. Read more…
International Technidyne Corporation Acquired by Warburg Pincus.
November 4, 2010
International Technidyne Corporation (ITC), formerly a subsidiary of Thoratec Corporation (Nasdaq: THOR), announced today the completion of its sale to affiliates of Warburg Pincus, LLC, the global private equity firm, in an all cash transaction valued at $55 million. ITC has been a recognized worldwide leader in hemostasis management and Point-of-Care (POC) testing for over 40 years. Immediately following the transaction, ITC then merged with Nexus Dx, Inc., a clinical diagnostics company focused on POC solutions. Read more…